The Parkinson’s Disease ADL scale is a self-report ADL scale designed to assess difficulties in daily activities due to PD.
5
5 minutes
5 minutes or less
Adult
18 - 64
yearsElderly Adult
65 +
yearsAlicia Esposito, PT, DPT, NCS & the PD EDGE Task Force of the Neurology Section of the APTA
Recommendations for use of the instrument from the Neurology Section of the American Physical Therapy Association’s Multiple Sclerosis Taskforce (MSEDGE), Parkinson’s Taskforce (PD EDGE), Spinal Cord Injury Taskforce (PD EDGE), Stroke Taskforce (StrokEDGE), Traumatic Brain Injury Taskforce (TBI EDGE), and Vestibular Taskforce (Vestibular EDGE) are listed below. These recommendations were developed by a panel of research and clinical experts using a modified Delphi process.
For detailed information about how recommendations were made, please visit:
Abbreviations: |
|
HR | Highly Recommend |
R | Recommend |
LS / UR | Reasonable to use, but limited study in target group / Unable to Recommend |
NR | Not Recommended |
Recommendations Based on Parkinson Disease Hoehn and Yahr stage:
| I | II | III | IV | V |
PD EDGE | LS/UR | LS/UR | LS/UR | LS/UR | LS/UR |
Recommendations for entry-level physical therapy education and use in research:
| Students should learn to administer this tool? (Y/N) | Students should be exposed to tool? (Y/N) | Appropriate for use in intervention research studies? (Y/N) | Is additional research warranted for this tool (Y/N) |
PD EDGE | No | No | No | Not reported |
The author states that the PADLS provides health professionals a reliable index of self-rated ADL, which takes little time to complete. The PADLS provides a single global rating and does not allow the individual to rate the severity of specific problems. The PADLS is not suitable for use in isolation and must complement existing measures in order to provide the health professional with more comprehensive information on how patients perceive their illness.
Do you see an error or have a suggestion for this instrument summary? Please e-mail us!
Parkinson’s Disease:
(Hobson, Edwards and Meara, 2001; n = 132 with clinically probable PD; mean age: 73.4(9.5); gender (male %): 55; onset of PD (years) 7.8(6.9); disease duration (years): 7.8 (6.9))
Mean PADLS score: 3.0 (1.2)
Parkinson’s Disease:
(Hobson, Edwards and Meara, 2001)
Parkinson’s Disease:
(Hobson, Edwards and Meara, 2001)
Hobson, J. P., Edwards, N. I., et al. (2001). "The Parkinson's Disease Activities of Daily Living Scale: a new simple and brief subjective measure of disability in Parkinson's disease." Clin Rehabil 15(3): 241-246.
Martinez-Martin, P., Rodriguez-Blazquez, C., et al. (2008). "Specific patient-reported outcome measures for Parkinson's disease: analysis and applications." Expert Rev Pharmacoecon Outcomes Res 8(4): 401-418.
We have reviewed more than 500 instruments for use with a number of diagnoses including stroke, spinal cord injury and traumatic brain injury among several others.